$JAZZ Recent Headlines Why eBay is like a divorcee, and

New Post Public Reply Private Reply Replies (0) Message Board

Dec 14, 2014 at 11:11 AM

$JAZZ Recent Headlines

Why eBay is like a divorcee, and a pharma pick that’s setting up for a pop 8:46 a.m. Nov. 7, 2014 - Shawn Langlois
There’s good news for speculative growth traders 1:40 p.m. Sept. 2, 2014 - The Trading Deck
Speculators live by the sword, die by the sword 2:13 p.m. July 8, 2014 - The Trading Deck
Two reasons a top is not yet imminent 1:12 p.m. July 3, 2014 - The Trading Deck
Apple and Beats,Tesla and Missouri car dealers, plus the missing momo 7:36 a.m. May 9, 2014 - Barbara Kollmeyer
Jazz Pharmaceuticals swings to first-quarter loss 9:53 p.m. May 8, 2014 - MarketWatch.com
Dow industrials hesitate at major resistance 10:23 a.m. April 23, 2014 - Michael Ashbaugh
The case for the bears weakens 1:55 p.m. Feb. 25, 2014 - The Trading Deck
A stock that protects your identity and your portfolio 11:56 a.m. Feb. 3, 2014 - The Trading Deck
13 stocks set to outperform in 2014 from Sabrient's David Brown 7:21 p.m. Jan. 14, 2014 - blogs.marketwatch.com
Sex bot on Volcker, dream gigs at Twitter and Wall Street's whiffs 8:27 a.m. Dec. 11, 2013 - Shawn Langlois
Dow industrials vie for all-time closing high 11:09 a.m. Nov. 21, 2013 - Michael Ashbaugh
One biotech that shouldn’t be missed 9:26 a.m. June 5, 2013 - The Trading Deck
Charting the S&P’s test of record territory 10:57 a.m. March 12, 2013 - Michael Ashbaugh
Charting the S&P’s test of record territory 10:51 a.m. March 12, 2013 - Michael Ashbaugh
S&P 500 nears next technical test 11:07 a.m. Nov. 30, 2012 - Michael Ashbaugh
Charting the fourth-quarter start 11:11 a.m. Oct. 2, 2012 - Michael Ashbaugh
Charting the fourth-quarter start 10:50 a.m. Oct. 2, 2012 - Michael Ashbaugh
4 stocks with charts pointing higher 5:58 a.m. Oct. 2, 2012 - The Trading Deck
Dow, Nasdaq hesitate at the range top 10:22 a.m. Sept. 24, 2012 - Michael Ashbaugh

Jazz kicks off Fast Track review process for VOD med 1:28 p.m. Dec. 12, 2014 - Seeking Alpha
Insider Trading Alert - JAZZ, ARE And SCLN Traded By Insiders 11:30 a.m. Dec. 12, 2014 - TheStreet.com
JAZZ Pharmaceuticals Slips After Dosing Issue on JZP-386 - Analyst Blog 2:39 p.m. Dec. 10, 2014 - Zacks.com
Pharmaceutical Giant Merck Buys Cubist Pharma 10:04 a.m. Dec. 9, 2014 - GuruFocus.com
Top Global Stocks: Jazz, Actavis In IBD's World List 5:39 p.m. Dec. 8, 2014 - Investors Business Daily
Jazz Pharmaceuticals (JAZZ) Starts Late-Stage Study on Xyrem - Analyst Blog 9:50 a.m. Dec. 3, 2014 - Zacks.com
Top Funds Gobble Up Tech And Medical Stocks 5:19 p.m. Dec. 2, 2014 - Investors Business Daily
Enrollment begins in Phase 3 trial for Xyrem expanded label 4:50 p.m. Dec. 2, 2014 - Seeking Alpha
Today's Momo Momentum Stock To Watch: Jazz Pharmaceuticals (JAZZ) 3:24 p.m. Nov. 26, 2014 - TheStreet.com
Insider Trading Alert - INTU, JAZZ And STNR Traded By Insiders 1:01 p.m. Nov. 26, 2014 - TheStreet.com
Riding The Bull Market With These 2 Momentum ETFs 2:10 p.m. Nov. 20, 2014 - Benzinga.com
Four International IBD 50 Stocks Near Buy Points 5:33 p.m. Nov. 19, 2014 - Investors Business Daily
Insider Trading Alert - JAZZ, SSS And PLKI Traded By Insiders 11:45 a.m. Nov. 19, 2014 - TheStreet.com
Five Ethical Drugmakers Keep Leadership Positions 5:27 p.m. Nov. 17, 2014 - Investors Business Daily
Growth Momentum Should Continue For This Pharmaceutical Company 9:50 p.m. Nov. 15, 2014 - GuruFocus.com
Is Jazz Pharmaceuticals (JAZZ) a Great Growth Stock? - Tale of the Tape 9:03 a.m. Nov. 14, 2014 - Zacks.com
Expect More Specialty Pharma Deals 7:40 a.m. Nov. 14, 2014 - Barrons.com
Sucampo-Takeda Sue Dr. Reddy's for Amitiza Patent Violation - Analyst Blog 4:30 p.m. Nov. 13, 2014 - Zacks.com
Update: Jazz Pharmaceuticals Q3 Earnings 11:00 a.m. Nov. 7, 2014 - Seeking Alpha
Jazz Pharmaceuticals Public Limited Company (JAZZ): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Nov. 5, 2014 - Zacks.com

Jazz Pharmaceuticals Initiates Rolling NDA Submission For Defibrotide For The Treatment Of Severe Hepatic Veno-Occlusive Disease 4:05 p.m. Dec. 11, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals and Concert Pharmaceuticals Provide JZP-386 Program Update 8:30 a.m. Dec. 9, 2014 - BusinessWire - BZX
Jazz Pharmaceuticals Announces First Patients Enrolled in Phase 3 Trial of Xyrem® (Sodium Oxybate) In Children And Adolescents Who Have Narcolepsy With Cataplexy 4:05 p.m. Dec. 2, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals To Present New Analysis Of Defibrotide Data In Patients With Hepatic Veno-Occlusive Disease (VOD) At ASH Annual Meeting 4:05 p.m. Dec. 2, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Participation in Two Investor Conferences 4:05 p.m. Nov. 25, 2014 - PR Newswire - PRF
Quarterly Financial Performance Reviews, Upcoming Events, and Medicare Plan Launch - Research Reports on Actavis, Celgene, UnitedHealth, Jazz and Endo 8:50 a.m. Nov. 10, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Participation in Two Investor Conferences 4:05 p.m. Nov. 6, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Third Quarter 2014 Financial Results And Updated Guidance 4:05 p.m. Nov. 4, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals to Report 2014 Third Quarter Financial Results on November 4, 2014 3:05 p.m. Oct. 21, 2014 - PR Newswire - PRF
Positive Study Results, Dividend, Regulatory Warning, Board Statements, and Technical Updates - Research Reports on Regeneron, CVS Health, Valeant, Allergan and Jazz 8:15 a.m. Oct. 7, 2014 - PR Newswire - PRF
Positive Study Results, Market Activity, Acquisition Proposal, Earnings Schedules, and Collaboration - Research Reports on Avanir, Jazz, Alere, Intuitive Surgical and GSK 8:05 a.m. Sept. 18, 2014 - PR Newswire - PRF
Market Activity, Drug Approval, Upcoming Conference, and Presentation of Clinical Data - Research Reports on Jazz, Keryx, Vertex, WellPoint and GSK 8:15 a.m. Sept. 10, 2014 - PR Newswire - PRF
Positive Drug Results, Market Activity Updates, Sustainability Report, Acquisitions, and Plant Closure - Research Reports on Repros, Jazz, Ingersoll-Rand, Nokia and Duke Energy 8:10 a.m. Sept. 2, 2014 - PR Newswire - PRF
Health Care Sector Stocks on our Radar -- Pacific Biosciences of California, Thermo Fisher Scientific, Lexicon Pharma, Vical, and Jazz Pharma 7:50 a.m. Aug. 27, 2014 - PR Newswire - PRF
Appointments, Market Activity, Regulatory Approvals, and Rights Acquisition - Research Reports on Nike, Morgan Stanley, Regeneron, Zimmer and Jazz 8:00 a.m. Aug. 21, 2014 - PR Newswire - PRF
Box Powers Cloud Collaboration for Leading Life Sciences Organizations 11:00 a.m. Aug. 20, 2014 - BusinessWire - BZX
Critical Alerts For Kate Spade & Co, Canadian Solar, Jazz Pharmaceuticals, InterMune and Micron. Released By InvestorsObserver 8:31 a.m. Aug. 14, 2014 - PR Newswire - PRF
Product Launch, Technical Updates, Clinical Study Results, Completion of Tender Offer, and Financial Result - Research Reports on Medtronic, Covidien, Johnson & Johnson, Merck and Jazz 8:20 a.m. Aug. 11, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Pricing of $500 Million of Exchangeable Senior Notes 5:30 a.m. Aug. 8, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Proposed Offering of $500 Million of Exchangeable Senior Notes 3:05 p.m. Aug. 6, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Posterity Health Boosts Network to Six New Markets

Expansion at Breakneck Speed Just like that, we've got Posterity Health making power moves across the country, staking claim in six major markets. Denver's very own fertility platform is on a roll, and this ain't just any rollout. We're talking partnerships like confetti in the air, dotting spots from the sunny Cali shores of Orange County to the bustling streets of...

3TREES Debuts Green Coatings to East African Market

3TREES Rocks East Africa's Construction Scene Nairobi's got a spark this week, and it's radiating straight from 3TREES' corner at the Big 5 Construct Kenya. With the Sarit Expo Centre buzzing from October 21, 2026, this Chinese company didn't just show up—they made one hell of an entrance. Presenting eco-friendly coating solutions, they pushed the 'Create Healthy Life'...

Globe Life Faces 8% Stock Dip Amidst Legal Scrutiny

Trouble Brews for Globe Life Investors Brace yourselves, folks. Globe Life Inc. (NYSE: GL) has found itself slap-bang in the middle of a potentially messy legal quagmire. The $7 million in excess Medicare Supplement claims that popped up due to a snail-like processing delay by the Centers for Medicare & Medicaid Services (CMS) have sent investors scrambling. And oh boy,...

Heart Attack vs. Cardiac Arrest: Know the Differences

Spotting the Crisis: Heart Attack or Cardiac Arrest? When your heart’s in trouble, knowing whether it’s a heart attack or cardiac arrest isn’t just some medical trivia—it could save a life. According to healthcare whiz Justin Doss from Beaumont, Texas, this difference can be the thin line between life and a dire outcome. What's the Deal with These Heart Events?...

Exploring Manual Lymphatic Massage: Key Benefits & Insights

The Surge in Popularity of Manual Lymphatic Massage There's a whole lotta buzz around manual lymphatic drainage (MLD) these days, and folks want to know if all that hype's got any juice. During National Massage Therapy Awareness Week, the American Massage Therapy Association (AMTA) lent a hand by spotlighting what the latest research has to say about this specialized...

Thermal Barrier Coatings Growth Fuels Industry Shifts

The Heat Is On: Thermal Barrier Coatings Surge The market for thermal barrier coatings is heating up like a Phoenix summer, slated to spike from $1.26 billion in 2026 to $1.55 billion by 2031, riding a tidy 4.19% CAGR. Aerospace engines and gas turbines—these hardcore markets are fueled by rising demand as engineers chase higher efficiency and better heat resistance....

Compal and ARC Cloud Forge AI Partnership

AI Infrastructure: A New Era of Collaboration Well, here's one that's got my old trader veins throbbing with excitement. Compal Electronics and ARC Cloud are shaking hands in a deal that could sketch out a bold new chapter in AI infrastructure. This ain't your run-of-the-mill tech announcement; it's a strategic dance aimed at supercharging the very backbone of large-scale...

Humberto Quintanar Strengthens McKinley Irvin's Seattle Team

Humberto Quintanar Makes His Move In a world where legal battles can shake lives to the core, McKinley Irvin is throwing another heavyweight into the ring. They’ve just pulled in Humberto Quintanar, a guy who knows his way around a courtroom like a cabbie knows a city's backstreets. This isn't just another seat-fillin' lawyer; Quintanar packs years of experience as a...

Venezuelan Crude Hits Texas: NABEP's Bold Move

Venezuelan Crude Docking in Texas Signals New Energy Dynamics Batten down the hatches, 'cause NABEP's Venezuelan crude has made a splashy arrival in Texas. We're talking 1 million barrels, folks, the first of its kind under a fresh U.S. deal. This ain't your grandpa's oil shipment from the Middle East that takes forever to get here—nope, this crude made a pit stop in...

Omnichat's $10M Series A: Scaling AI for Global Reach

Omnichat Secures Funding to Transform Commerce Well, folks, they're calling it a smart move—or a gamble, depending on who you ask. Omnichat just snagged a tidy $10 million from a Series A, led by Openspace Capital. They're pouring this cash into scaling what they call the 'Agentic AI' platform, a bevy of AI agents poised to shake up the marketing, sales, and customer...